BRPI1007812A2 - lipoatrofia cosmética medicinal - Google Patents
lipoatrofia cosmética medicinalInfo
- Publication number
- BRPI1007812A2 BRPI1007812A2 BRPI1007812A BRPI1007812A BRPI1007812A2 BR PI1007812 A2 BRPI1007812 A2 BR PI1007812A2 BR PI1007812 A BRPI1007812 A BR PI1007812A BR PI1007812 A BRPI1007812 A BR PI1007812A BR PI1007812 A2 BRPI1007812 A2 BR PI1007812A2
- Authority
- BR
- Brazil
- Prior art keywords
- medicinal cosmetic
- lipoatrophy
- cosmetic lipoatrophy
- medicinal
- cosmetic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20906509P | 2009-03-02 | 2009-03-02 | |
| US61/209,065 | 2009-03-02 | ||
| PCT/BR2010/000059 WO2010099587A1 (en) | 2009-03-02 | 2010-03-02 | Medicinal cosmetic lipoatrophy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI1007812A2 true BRPI1007812A2 (pt) | 2016-02-23 |
| BRPI1007812B1 BRPI1007812B1 (pt) | 2017-09-26 |
Family
ID=42709157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1007812-6A BRPI1007812B1 (pt) | 2009-03-02 | 2010-03-02 | Lipoatrofia cosmetic medicinal |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US9220717B2 (pt) |
| EP (1) | EP2403502A4 (pt) |
| JP (1) | JP6006940B2 (pt) |
| KR (1) | KR20120104487A (pt) |
| CN (1) | CN102341109A (pt) |
| AU (1) | AU2010220830B2 (pt) |
| BR (1) | BRPI1007812B1 (pt) |
| CA (1) | CA2754008C (pt) |
| MX (1) | MX337850B (pt) |
| RU (1) | RU2530629C2 (pt) |
| WO (1) | WO2010099587A1 (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014520892A (ja) * | 2011-07-20 | 2014-08-25 | アラーガン、インコーポレイテッド | 脂肪沈着物を処置するための方法におけるボツリヌス毒素の使用 |
| US10493024B2 (en) * | 2015-10-12 | 2019-12-03 | Hk Tumescent Pharma Corporation | Tumescent infiltration drug delivery of high subcutaneous drug concentrations with prolonged local and systemic effects and minimal local or systemic toxicity |
| US11241412B2 (en) | 2015-10-12 | 2022-02-08 | Hk Pharma | Tumescent infiltration drug delivery of cannabinoids |
| KR101972588B1 (ko) * | 2018-07-31 | 2019-04-26 | 정채홍 | 지방분해 및 지방제거 시술 전처리용 조성물 |
| EP3713551B1 (en) | 2018-10-16 | 2023-06-07 | Polithera, Inc. | Alcohol-based compositions and uses thereof |
| WO2020160328A1 (en) * | 2019-01-31 | 2020-08-06 | Hk Pharma | Tumescent infiltration drug delivery of cannabinoids |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5192528A (en) * | 1985-05-22 | 1993-03-09 | Liposome Technology, Inc. | Corticosteroid inhalation treatment method |
| US20040141925A1 (en) * | 1998-11-12 | 2004-07-22 | Elan Pharma International Ltd. | Novel triamcinolone compositions |
| US7098189B2 (en) * | 2002-12-16 | 2006-08-29 | Kimberly-Clark Worldwide, Inc. | Wound and skin care compositions |
| US20050143347A1 (en) * | 2003-12-22 | 2005-06-30 | Aventis Pharma Deutschland Gmbh | Medicinal lipolysis of accumulations of fat |
| DE10361067A1 (de) * | 2003-12-22 | 2005-07-14 | Aventis Pharma Deutschland Gmbh | Medikamentöse Lipolyse von Fettansammlungen |
| US20060127468A1 (en) * | 2004-05-19 | 2006-06-15 | Kolodney Michael S | Methods and related compositions for reduction of fat and skin tightening |
| ES2372499T3 (es) * | 2004-05-19 | 2012-01-20 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Uso de un detergente para la eliminación no quirúrgica de grasa. |
| KR20070086101A (ko) * | 2004-12-14 | 2007-08-27 | 메나리니 리케르체 에스.피.아. | 셀룰라이트 치료용 약제학적 조성물 |
| US20060211665A1 (en) * | 2005-03-17 | 2006-09-21 | Ranawat Chitranjan S | Reduction of postoperative pain medication |
| CA2610022A1 (en) * | 2005-06-06 | 2006-12-14 | Georgetown University | Compositions and methods for lipo modeling |
-
2010
- 2010-03-02 JP JP2011552282A patent/JP6006940B2/ja active Active
- 2010-03-02 CN CN2010800103120A patent/CN102341109A/zh active Pending
- 2010-03-02 AU AU2010220830A patent/AU2010220830B2/en not_active Ceased
- 2010-03-02 RU RU2011139015/15A patent/RU2530629C2/ru active
- 2010-03-02 EP EP10748244A patent/EP2403502A4/en not_active Withdrawn
- 2010-03-02 MX MX2011009212A patent/MX337850B/es active IP Right Grant
- 2010-03-02 WO PCT/BR2010/000059 patent/WO2010099587A1/en not_active Ceased
- 2010-03-02 KR KR1020117022756A patent/KR20120104487A/ko not_active Ceased
- 2010-03-02 CA CA2754008A patent/CA2754008C/en active Active
- 2010-03-02 US US13/810,022 patent/US9220717B2/en active Active
- 2010-03-02 BR BRPI1007812-6A patent/BRPI1007812B1/pt not_active IP Right Cessation
-
2014
- 2014-04-02 US US14/243,483 patent/US9408857B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI1007812B1 (pt) | 2017-09-26 |
| EP2403502A4 (en) | 2012-11-07 |
| JP2012519189A (ja) | 2012-08-23 |
| US20140213562A1 (en) | 2014-07-31 |
| US9408857B2 (en) | 2016-08-09 |
| RU2011139015A (ru) | 2013-04-10 |
| AU2010220830A1 (en) | 2011-10-13 |
| US9220717B2 (en) | 2015-12-29 |
| RU2530629C2 (ru) | 2014-10-10 |
| KR20120104487A (ko) | 2012-09-21 |
| CN102341109A (zh) | 2012-02-01 |
| JP6006940B2 (ja) | 2016-10-12 |
| CA2754008C (en) | 2016-04-26 |
| CA2754008A1 (en) | 2010-09-10 |
| AU2010220830B2 (en) | 2016-07-14 |
| WO2010099587A1 (en) | 2010-09-10 |
| MX2011009212A (es) | 2011-12-06 |
| US20130116223A1 (en) | 2013-05-09 |
| MX337850B (es) | 2016-03-23 |
| EP2403502A1 (en) | 2012-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0912213A2 (pt) | preparação cosmética | |
| EP2432348A4 (en) | COSMETIC APPLICATOR COMPRESSIBLE | |
| UA17897S (uk) | Губка косметична | |
| NO20092808A (no) | Hårføner | |
| FR2933868B1 (fr) | Compositions cosmetiques | |
| EP2515946A4 (en) | NANOCONJUGATES AND COMPOSITIONS OF NANOCONJUGATES | |
| BR112013009589A2 (pt) | composição de cuidados com o cabelo | |
| BRPI1014159A2 (pt) | cosmético capilar | |
| EP2389920A4 (en) | EMULSIFIED COSMETIC MATERIAL | |
| BRPI1010140A2 (pt) | composição de xampu condicionante | |
| FR2942702B1 (fr) | Applicateur cosmetique | |
| EP2490542A4 (en) | DERMATOLOGICAL AND COSMETIC COMPOSITIONS | |
| BRPI0910019A2 (pt) | composição cosmética | |
| BRPI1014898A2 (pt) | cosmético capilar. | |
| EP2433616A4 (en) | COSMETIC PREPARATION | |
| EP2236149A4 (en) | MEDICAL COMPOSITION | |
| EP2229933A4 (en) | COSMETIC COMPOSITION FOR THE HAIR | |
| DE112008003934A5 (de) | Kosmetikmaske | |
| FR2957252B1 (fr) | Composition cosmetique | |
| EP2460433A4 (en) | CASE FOR COSMETICS | |
| EP2623092A4 (en) | COSMETIC COMPOSITION | |
| BRPI1008015A2 (pt) | composição de fixação de cabelo | |
| IT1392161B1 (it) | Prodotto cosmetico compattato | |
| BR112013012262A2 (pt) | cosmético de cabelo | |
| EP2403502A4 (en) | MEDICAL-COSMETIC LIPOATROPHY |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B65X | Notification of requirement for priority examination of patent application | ||
| B65Y | Grant of priority examination of the patent application (request complies with dec. 132/06 of 20061117) | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B25G | Requested change of headquarter approved |
Owner name: DORIS HEXSEL (BR/RS) |
|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B25D | Requested change of name of applicant approved |
Owner name: DORIS MARIA HEXSEL (BR/RS) |
|
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] | ||
| B25C | Requirement related to requested transfer of rights |
Free format text: A FIM DE ATENDER A(S) TRANSFERENCIA(S), REQUERIDA(S) ATRAVES DA PETICAO NO 870190141215, DE 30/12/2019, E NECESSARIO:1. QUE O DOCUMENTO QUE COMPROVA O ATO REQUERIDO ESTEJA ACOMPANHADO DE SUA TRADUCAOJURAMENTADA;2. QUE O TAL DOCUMENTO ESTEJA ACOMPANHADO DA APOSTILA DE HAIA OU DA RESPECTIVA LEGALIZACAOCONSULAR;3. APRESENTAR PROCURACAO EM VERNACULO QUE ATRIBUA, AO SIGNATARIO DA PETICAO SUPRA, PODERESPARA AGIR EM NOME DA CESSIONARIA;4. APRESENTAR GRU REFERENTE AO CUMPRIMENTO DA PRESENTE EXIGENCIA. |
|
| B25A | Requested transfer of rights approved | ||
| B25L | Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled |
Free format text: ANULADA A PUBLICACAO CODIGO 25.1 NA RPI NO 2577 DE 26/05/2020 POR TER SIDO INDEVIDA. |
|
| B25A | Requested transfer of rights approved | ||
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 16A ANUIDADE. |